Epidemiological characteristics of concomitant diseases (tuberculosis and parenteral viral hepatitides) among the population of Moscow


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To identify and evaluate the epidemiological characteristics of the concomitant incidence of tuberculosis (TB) and parenteral viral hepatitides (PVH) among the population of Moscow in the period 2009 to 2017. Materials and methods. Data on concurrent PVH + TB diseases were obtained on the basis of an analysis of 276 574 infectious disease registration cards available in the Moscow Citywide Automatic Information System «ORUIB» for registering the cases of infectious and parasitic diseases and the statistical data of the Center of Hygiene and Epidemiology in the City of Moscow. Epidemiological and statistical methods were used. Results. The number of patients with the concomitant forms ranged from 311 to 406cases annually (the incidence rate was 3 to 3.7 0/0000), while every ten patients with TB were infected with parenteral hepatitis viruses. These patients were more often found to have severe forms of TB: generalized TB and disseminated TB were by 5.8 and 2.6 times, respectively. The main cause of death was TB (60 to 80% of cases). The risk for a fatal outcome was significantly higher (by 32.0%) in the group of patients with TB burdened by PVH. The chronic forms of hepatitis B and C in patients with TB were significantly more common (by 39 and 116 times, respectively) than among the total population (p <0.05). The incidence of all clinical forms of PVH in patients with TB was 46 times higher than that among the total population (the correlation coefficient was 0.87). Conclusion. Every ten patients with TB were infected with PVH viruses. The severe forms of TB can contribute to the long-term release of mycobacteria into the environment and increase the number of sources of infection. The modern features of the epidemic situation of concomitant incidence of PVH + TB were revealed in the population of Moscow in the period 2009 to 2017.

全文:

受限制的访问

作者简介

D. Solovyev

Center of Hygiene and Epidemiology in the City of Moscow

Email: dv_soloviev@list.ru
Cand. Med. Sci., Head, Antiepidemic Department Moscow, Russia

O. Smirnova

Center of Hygiene and Epidemiology in the City of Moscow

Email: dv_soloviev@list.ru
Epidemiologist, Antiepidemic Department Moscow, Russia

A. Asratyan

Honored Academician N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: zasratyan@yahoo.com
MD, Leading Researcher, Department of Epidemiology Moscow, Russia

参考

  1. Доклад ВОЗ «О глобальной борьбе с туберкулезом 2016». Женева: ВОЗ, 2016. http://whodc.mednet.ru/ru/osnovnye-publikaczii/tuberkulez/ 2561.html
  2. Информационный бюллетень ВОЗ. Туберкулез. Женева: ВОЗ, 2017. http://www.who.int/mediacentre/factsheets/fs104/ru/
  3. Global hepatitis report. WHO. Geneva: WHO, 2017; 7-19. http://www.whogis.com/hepatitis/publications/global-hepatitis-report2017/en/
  4. Верткин А.Л., Румянцев М.А., Скотников А.С. Коморбидность. Клиническая медицина 2012; (10): 4-11.
  5. Савилов Е.Д., Колесников С.Н., Брико Н.И. Коморбидность в эпидемиологии - новый тренд в исследованиях общественного здоровья. Журн. микробиол. 2016; (4): 66-75.
  6. Шкарин В.В., Благонравова А.С., Чубукова О.А. Эпидемиологический подход к изучению сочетанной инфекционной патологии. Эпидемиол. инфекц. болезни. Актуал. вопр. 2016; (6): 67-75.
  7. Кляритская И.Л., Максимова Е.В. Современный взгляд на проблему лекарственных поражений печени. Гастроэнтерология (Симферополь) 2011; (382): 30-35.
  8. Aghaa A.M., El-Mahalawya I.I., Seleemb H.M. et al. Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity. Egyptian Journal Chest Diseases and Tuberculosis 2015; 64: 91-6.
  9. Асратян А.А., Соловьев Д.В., Русакова Е.В. Туберкулез в сочетании с парентеральными вирусными гепатитами: заболеваемость сочетанными формами. Туберкулез и болезни легких 2014; (11): 54-7.
  10. Барамзина С.В. Хронические вирусные гепатиты B и C у больных туберкулезом: удельный" вес нозоформ, динамические изменения. Журнал инфектологии 2015; 7(2): 47-53.
  11. Сафронов А.Е. Проблема сочетанных инфекций туберкулеза и вирусных гепатитов. Современные наукоемкие технологии 2006; (3): 85-6.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2019
##common.cookie##